Protection Analysis

Panacea community - Protection sales by quarter  

Product Q4 19 Q1 19 Q2 19 Q3 19 Grand total
Crit. Illness £3,598,373 £3,932,558 £4,008,094 £3,813,663 £15,352,689
Decreasing Term with CI £3,466,525 £3,089,024 £3,527,045 £3,689,933 £13,772,527
Income Prot. £4,867,486 £3,272,223 £3,223,190 £3,177,153 £14,540,051
Mortgage Term £7,111,704 £6,388,943 £6,341,583 £6,127,844 £25,970,074
Relevant Life £2,092,794 £2,100,165 £2,514,808 £2,224,329 £8,932,096
Term £16,475,065 £16,764,279 £16,441,198 £15,727,333 £65,407,875
Term with Critical Illness £5,347,108 £5,866,624 £5,959,796 £5,507,361 £22,680,889
Whole of Life £4,114,938 £4,205,098 £3,380,903 £4,078,319 £15,779,258
Equity Release £38,589,732 £31,694,609 £29,798,534 £30,927,329 £131,010,204
Grand total £85,663,724 £77,313,524 £75,195,152 £75,273,265 £313,445,664

 

Q4 18 to Q3 19 total Protection sales  

Product Non User Sales Panacea Community Sales Total Market Share
Crit. Illness £31,466,753 £15,352,689 £46,819,442 33%
Decreasing Term with CI £35,800,691 £13,772,527 £49,573,219 28%
Income Prot. £33,341,974 £14,540,051 £47,882,026 30%
Mortgage Term £76,287,324 £25,970,074 £102,257,398 25%
Relevant Life £11,421,364 £8,932,096 £20,353,460 44%
Term £163,409,199 £65,407,875 £228,817,074 29%
Term with Critical Illness £60,207,853 £22,680,889 £82,888,743 27%
Whole of Life £21,778,579 £15,779,258 £37,557,836 42%

Please contact sarahpaul@panaceaadviser.com if you are interested in speaking to us further.

Email this article Print Share on Twitter Share on LinkedIn Share on Facebook Share on Google+